Report cover image

Global Biopharmaceutical CDMO Supply, Demand and Key Producers, 2023-2029

Publisher GlobalInfoResearch
Published Oct 17, 2023
Length 122 Pages
SKU # GFSH18260853

Description

Global Biopharmaceutical CDMO Supply, Demand and Key Producers, 2023-2029


The global Biopharmaceutical CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Biopharmaceutical CDMO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Biopharmaceutical CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biopharmaceutical CDMO that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Biopharmaceutical CDMO total market, 2018-2029, (USD Million)

Global Biopharmaceutical CDMO total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Biopharmaceutical CDMO total market, key domestic companies and share, (USD Million)

Global Biopharmaceutical CDMO revenue by player and market share 2018-2023, (USD Million)

Global Biopharmaceutical CDMO total market by Type, CAGR, 2018-2029, (USD Million)

Global Biopharmaceutical CDMO total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Biopharmaceutical CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, WuXi AppTec, Catalent, Thermo Fisher, Recipharm, Samsung Biologics, Siegfried, Delpharm and Boehringer Ingelheim, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biopharmaceutical CDMO market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Biopharmaceutical CDMO Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Biopharmaceutical CDMO Market, Segmentation by Type
Development and Manufacturing CDMOs
Clinical Trial Material CDMOs
Fill-Finish CDMOs
Other

Global Biopharmaceutical CDMO Market, Segmentation by Application
Pharmaceutical Company
Biotechnology Company
Other

Companies Profiled:
Lonza
WuXi AppTec
Catalent
Thermo Fisher
Recipharm
Samsung Biologics
Siegfried
Delpharm
Boehringer Ingelheim
Aenova Group
AGC Parma Chemicals
GenScript
ProBioGen
KBI Biopharma
3P Biopharmaceuticals
Rentschler Biopharma
Northway Biotech

Key Questions Answered

1. How big is the global Biopharmaceutical CDMO market?

2. What is the demand of the global Biopharmaceutical CDMO market?

3. What is the year over year growth of the global Biopharmaceutical CDMO market?

4. What is the total value of the global Biopharmaceutical CDMO market?

5. Who are the major players in the global Biopharmaceutical CDMO market?

Table of Contents

122 Pages
1 Supply Summary
2 Demand Summary
3 World Biopharmaceutical CDMO Companies Competitive Analysis
4 United States VS China VS Rest of World (by Headquarter Location)
5 Market Analysis by Type
6 Market Analysis by Application
7 Company Profiles
8 Industry Chain Analysis
9 Research Findings and Conclusion
10 Appendix

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us